Adipogenesis is differentially impaired by thyroid hormone receptor mutant isoforms

Area of Science:

• Endocrinology
• Molecular Biology
• Cell Biology

Background:

• Thyroid hormone receptors (TRs) regulate metabolism.
• Adipogenesis, the process of fat cell differentiation, is crucial for energy homeostasis.
• The specific roles of TR isoforms in adipogenesis are not fully understood.

Purpose of the Study:

• To investigate the isoform-specific roles of thyroid hormone receptors (TRs) in adipogenesis using a loss-of-function approach.
• To determine the impact of dominant-negative mutations in TRalpha1 and TRbeta1 on adipogenesis in 3T3-L1 cells.

Main Methods:

• Generated 3T3-L1 cells stably expressing dominant-negative TRalpha1 (TRalpha1PV) or TRbeta1 (TRbeta1PV) mutants.
• Assessed adipogenesis by measuring lipid droplet accumulation.
• Quantified mRNA and protein levels of adipogenic regulators (PPARgamma, C/EBPalpha) and target genes (Lpl, aP2).
• Utilized chromatin immunoprecipitation assays to examine TR binding to gene promoters.

Main Results:

• Thyroid hormone (T3) significantly increased adipogenesis and expression of PPARgamma and C/EBPalpha in control cells.
• TRalpha1PV expression reduced adipogenesis by 94%, while TRbeta1PV reduced it by 54%.
• TRalpha1PV more strongly repressed PPARgamma and C/EBPalpha expression and downstream target genes compared to TRbeta1PV.
• TRalpha1PV showed greater recruitment to the C/ebpalpha promoter than TRbeta1PV.

Conclusions:

• Impaired adipogenesis by mutant TRs is dependent on the TR isoform.
• TRalpha1 has a more dominant role in promoting adipogenesis than TRbeta1.
• TR isoform-specific ligands could be developed for treating lipid abnormalities.